(WELL) Welltower - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US95040Q1040
Stock: Seniors Housing, Healthcare Real Estate, Senior Living, Wellness Communities
Total Rating 46
Risk 55
Buy Signal 0.13
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.75% |
| Yield on Cost 5y | 5.10% |
| Yield CAGR 5y | 3.68% |
| Payout Consistency | 97.5% |
| Payout Ratio | 2.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 19.6% |
| Relative Tail Risk | -0.24% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.51 |
| Alpha | 32.63 |
| Character TTM | |
|---|---|
| Beta | 0.301 |
| Beta Downside | 0.434 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.05% |
| CAGR/Max DD | 2.74 |
Description: WELL Welltower January 27, 2026
Welltower Inc. (NYSE: WELL) is an S&P 500-listed REIT that concentrates on senior-focused rental housing across the U.S., U.K., and Canada. The company markets its 2,000+ communities as a hybrid of housing and hospitality, emphasizing “micro-market” locations and a vertically integrated operating model that it describes as a real-estate wrapper around an operating business.
Key recent metrics (as of Q4 2024): occupancy averaged 94.2% across the portfolio, same-store rent growth was 5.1% YoY, and net operating income (NOI) rose 8.3% year-over-year, supporting a current dividend yield of roughly 5.5%. The senior housing sector is being driven by a 3.2% annual increase in the U.S. population aged 65+, and by tighter supply in high-demand “life-stage” markets, which historically compresses cap rates to the low-7% range for premium assets.
For a deeper, data-rich assessment of WELL’s valuation dynamics, you may find ValueRay’s analytical tools useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 958.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.81 > 1.0 |
| NWC/Revenue: 91.01% < 20% (prev 73.19%; Δ 17.82% < -1%) |
| CFO/TA 0.05 > 3% & CFO 2.79b > Net Income 958.0m |
| Net Debt (11.36b) to EBITDA (3.50b): 3.24 < 3 |
| Current Ratio: 5.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (685.4m) vs 12m ago 10.85% < -2% |
| Gross Margin: 39.21% > 18% (prev 0.39%; Δ 3881 % > 0.5%) |
| Asset Turnover: 18.09% > 50% (prev 15.02%; Δ 3.07% > 0%) |
| Interest Coverage Ratio: 2.49 > 6 (EBITDA TTM 3.50b / Interest Expense TTM 602.6m) |
Altman Z'' 0.27
| A: 0.15 (Total Current Assets 10.96b - Total Current Liabilities 2.03b) / Total Assets 59.50b |
| B: -0.15 (Retained Earnings -8.75b / Total Assets 59.50b) |
| C: 0.03 (EBIT TTM 1.50b / Avg Total Assets 54.23b) |
| D: -0.40 (Book Value of Equity -8.28b / Total Liabilities 20.48b) |
| Altman-Z'' Score: 0.27 = B |
Beneish M -2.91
| DSRI: 0.93 (Receivables 4.15b/3.33b, Revenue 9.81b/7.35b) |
| GMI: 1.00 (GM 39.21% / 39.38%) |
| AQI: 0.94 (AQ_t 0.79 / AQ_t-1 0.85) |
| SGI: 1.33 (Revenue 9.81b / 7.35b) |
| TATA: -0.03 (NI 958.0m - CFO 2.79b) / TA 59.50b) |
| Beneish M-Score: -2.91 (Cap -4..+1) = A |
What is the price of WELL shares?
As of February 08, 2026, the stock is trading at USD 195.92 with a total of 2,290,323 shares traded.
Over the past week, the price has changed by +4.01%, over one month by +5.53%, over three months by +4.75% and over the past year by +40.01%.
Over the past week, the price has changed by +4.01%, over one month by +5.53%, over three months by +4.75% and over the past year by +40.01%.
Is WELL a buy, sell or hold?
Welltower has received a consensus analysts rating of 4.30.
Therefore, it is recommended to buy WELL.
- StrongBuy: 10
- Buy: 6
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the WELL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 214.2 | 9.3% |
| Analysts Target Price | 214.2 | 9.3% |
| ValueRay Target Price | 268.4 | 37% |
WELL Fundamental Data Overview February 02, 2026
P/E Trailing = 128.1361
P/E Forward = 78.125
P/S = 13.0479
P/B = 3.2883
P/EG = 3.6218
Revenue TTM = 9.81b USD
EBIT TTM = 1.50b USD
EBITDA TTM = 3.50b USD
Long Term Debt = 16.85b USD (from longTermDebt, last quarter)
Short Term Debt = 62.7m USD (from shortTermDebt, two quarters ago)
Debt = 18.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.36b USD (from netDebt column, last quarter)
Enterprise Value = 140.63b USD (129.28b + Debt 18.16b - CCE 6.81b)
Interest Coverage Ratio = 2.49 (Ebit TTM 1.50b / Interest Expense TTM 602.6m)
EV/FCF = 50.73x (Enterprise Value 140.63b / FCF TTM 2.77b)
FCF Yield = 1.97% (FCF TTM 2.77b / Enterprise Value 140.63b)
FCF Margin = 28.26% (FCF TTM 2.77b / Revenue TTM 9.81b)
Net Margin = 9.77% (Net Income TTM 958.0m / Revenue TTM 9.81b)
Gross Margin = 39.21% ((Revenue TTM 9.81b - Cost of Revenue TTM 5.96b) / Revenue TTM)
Gross Margin QoQ = 41.28% (prev 39.80%)
Tobins Q-Ratio = 2.36 (Enterprise Value 140.63b / Total Assets 59.50b)
Interest Expense / Debt = 0.89% (Interest Expense 162.1m / Debt 18.16b)
Taxrate = 4.28% (12.5m / 293.1m)
NOPAT = 1.44b (EBIT 1.50b * (1 - 4.28%))
Current Ratio = 5.40 (Total Current Assets 10.96b / Total Current Liabilities 2.03b)
Debt / Equity = 0.47 (Debt 18.16b / totalStockholderEquity, last quarter 38.76b)
Debt / EBITDA = 3.24 (Net Debt 11.36b / EBITDA 3.50b)
Debt / FCF = 4.10 (Net Debt 11.36b / FCF TTM 2.77b)
Total Stockholder Equity = 35.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.77% (Net Income 958.0m / Total Assets 59.50b)
RoE = 2.73% (Net Income TTM 958.0m / Total Stockholder Equity 35.14b)
RoCE = 2.89% (EBIT 1.50b / Capital Employed (Equity 35.14b + L.T.Debt 16.85b))
RoIC = 2.81% (NOPAT 1.44b / Invested Capital 51.15b)
WACC = 6.26% (E(129.28b)/V(147.44b) * Re(7.02%) + D(18.16b)/V(147.44b) * Rd(0.89%) * (1-Tc(0.04)))
Discount Rate = 7.02% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 11.39%
[DCF Debug] Terminal Value 86.82% ; FCFF base≈2.42b ; Y1≈2.88b ; Y5≈4.54b
Fair Price DCF = 155.8 (EV 118.27b - Net Debt 11.36b = Equity 106.92b / Shares 686.3m; r=6.26% [WACC]; 5y FCF grow 20.56% → 2.90% )
EPS Correlation: 50.83 | EPS CAGR: -36.58% | SUE: -3.55 | # QB: 0
Revenue Correlation: 97.75 | Revenue CAGR: 21.45% | SUE: -0.41 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.80 | Chg30d=+0.055 | Revisions Net=+0 | Analysts=6
EPS next Year (2026-12-31): EPS=2.18 | Chg30d=-0.250 | Revisions Net=+0 | Growth EPS=+42.1% | Growth Revenue=+17.9%
P/E Forward = 78.125
P/S = 13.0479
P/B = 3.2883
P/EG = 3.6218
Revenue TTM = 9.81b USD
EBIT TTM = 1.50b USD
EBITDA TTM = 3.50b USD
Long Term Debt = 16.85b USD (from longTermDebt, last quarter)
Short Term Debt = 62.7m USD (from shortTermDebt, two quarters ago)
Debt = 18.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.36b USD (from netDebt column, last quarter)
Enterprise Value = 140.63b USD (129.28b + Debt 18.16b - CCE 6.81b)
Interest Coverage Ratio = 2.49 (Ebit TTM 1.50b / Interest Expense TTM 602.6m)
EV/FCF = 50.73x (Enterprise Value 140.63b / FCF TTM 2.77b)
FCF Yield = 1.97% (FCF TTM 2.77b / Enterprise Value 140.63b)
FCF Margin = 28.26% (FCF TTM 2.77b / Revenue TTM 9.81b)
Net Margin = 9.77% (Net Income TTM 958.0m / Revenue TTM 9.81b)
Gross Margin = 39.21% ((Revenue TTM 9.81b - Cost of Revenue TTM 5.96b) / Revenue TTM)
Gross Margin QoQ = 41.28% (prev 39.80%)
Tobins Q-Ratio = 2.36 (Enterprise Value 140.63b / Total Assets 59.50b)
Interest Expense / Debt = 0.89% (Interest Expense 162.1m / Debt 18.16b)
Taxrate = 4.28% (12.5m / 293.1m)
NOPAT = 1.44b (EBIT 1.50b * (1 - 4.28%))
Current Ratio = 5.40 (Total Current Assets 10.96b / Total Current Liabilities 2.03b)
Debt / Equity = 0.47 (Debt 18.16b / totalStockholderEquity, last quarter 38.76b)
Debt / EBITDA = 3.24 (Net Debt 11.36b / EBITDA 3.50b)
Debt / FCF = 4.10 (Net Debt 11.36b / FCF TTM 2.77b)
Total Stockholder Equity = 35.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.77% (Net Income 958.0m / Total Assets 59.50b)
RoE = 2.73% (Net Income TTM 958.0m / Total Stockholder Equity 35.14b)
RoCE = 2.89% (EBIT 1.50b / Capital Employed (Equity 35.14b + L.T.Debt 16.85b))
RoIC = 2.81% (NOPAT 1.44b / Invested Capital 51.15b)
WACC = 6.26% (E(129.28b)/V(147.44b) * Re(7.02%) + D(18.16b)/V(147.44b) * Rd(0.89%) * (1-Tc(0.04)))
Discount Rate = 7.02% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 11.39%
[DCF Debug] Terminal Value 86.82% ; FCFF base≈2.42b ; Y1≈2.88b ; Y5≈4.54b
Fair Price DCF = 155.8 (EV 118.27b - Net Debt 11.36b = Equity 106.92b / Shares 686.3m; r=6.26% [WACC]; 5y FCF grow 20.56% → 2.90% )
EPS Correlation: 50.83 | EPS CAGR: -36.58% | SUE: -3.55 | # QB: 0
Revenue Correlation: 97.75 | Revenue CAGR: 21.45% | SUE: -0.41 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.80 | Chg30d=+0.055 | Revisions Net=+0 | Analysts=6
EPS next Year (2026-12-31): EPS=2.18 | Chg30d=-0.250 | Revisions Net=+0 | Growth EPS=+42.1% | Growth Revenue=+17.9%